Dermot Cox - Royal College of Surgeons in Ireland

基本信息

Career Trajectory

Bio

Study of the host response to infection with emphasis on the role of platelets

Research Interests

Papers共 285 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Assessment of the Haemostatic Potential of Platelets Readied for Transfusion

Unwana Emagha, Khawla Yousif, Michelle Duff, Edwina Geraghty, Janice O'Shaughnessy,Philip Murphy, Stefano Verardi,Stephen Marcella,Roy Bentley,Dermot Cox

TH open companion journal to thrombosis and haemostasis (2025): a25256768-a25256768

Cited0Views0WOSBibtex

WS04.05 Sustained Improvement in Abdominal Symptoms Measured by the CFAbd-Score over 2 Years of Treatment with Elexacaftor/tezacaftor/ivacaftor in People with CF Aged ≥12 Years: Results from the RECOVER Study

P. McNally,J.C. Davies,K. Lester,L. Perrem,M. Williamson,D. Cox,E. McKone,B. Linnane,D. Downey,C. Zagoya, J. Mainz

Journal of Cystic Fibrosis (2024): S8-S8

Cited0Views0Bibtex

125 Improvement in Abdominal Symptoms (Cfabd-Score) and Gut Inflammation over 12 Months of Treatment with Elexacaftor/tezacaftor/ivacaftor in Children with CF Aged 6 to 11—results from the RECOVER Study

P. McNally, J. Davies, R. Cregan,B. Linnane,B. Elnazir,M. Williamson,E. McKone,D. Cox,D. Downey,C. Zagoya, J. Mainz

Journal of Cystic Fibrosis（2024）

Cited0Views0Bibtex

WS13.01 Proteomic Analysis of Nasal Lavage Fluid Samples in People with Cystic Fibrosis after One Year of Treatment with Elexacaftor/ivacaftor/tezacaftor – the RECOVER Study

S. Nolan,S. Weldon,K. Lester,B. Elnazir,M. Williamson,D. Cox,B. Linnane,P. O’Regan,L. Kirwan,E. McKone, A. Reid,J. Davies,P. McNally,D. Downey,C. Taggart

Journal of Cystic Fibrosis（2024）

Cited0Views0Bibtex

558 Challenges Faced by Parents of Children with Cystic Fibrosis in Ireland: the Irish Comparative Outcome Study of Cystic Fibrosis

R. Bhatnagar,N. Bhardwaj, G. Masukume,B. Linnane,M. Herzig,M. Ni Chroinin,D. Mullane,D. Cox,P. McNally,S. Javadpour,B. Elnazir,P. Greally,F. Healy, M. Williamson,D. Slattery, G. Lancaster,C. Glasscoe,R. Segurado,K.W. Southern,P. Fitzpatrick

Journal of Cystic Fibrosis (2024): S307-S308

Cited0Views0Bibtex

EPS4.02 Exploring Barriers to Treatment Adherence in People with Cystic Fibrosis: Insights from the RECOVER Study at 24 Months

S. Sutton,J. Hayden,M. Howlett,J. Davies,K. Lester,B. Elnazir,M. Williamson,E. McKone,D. Cox,B. Linnane,P. O’Regan,L. Kirwan,A. Quittner,P. McNally

Journal of Cystic Fibrosis (2024): S44-S44

Cited0Views0Bibtex

On-treatment Platelet Reactivity at Low Shear Stress and Platelet Activation Status on Aspirin or Clopidogrel Monotherapy in Patients with TIA or Ischaemic Stroke

Soon Tjin Lim, Murphy Stephen, Deirdre Smith,Ronan Collins,Tara Coughlan, Sinead Murphy, Alan McCarthy,Bridget Egan,Su-Yin Lim,Dermot Cox,Dominick McCabe

crossref（2024）

Cited0Views0Bibtex

Aspirin Response Testing: Time for Patient-Specific Tailored Care

Irene Regan,Sean Kelleher,Dermot Cox,Colin J. McMahon

Pediatric Cardiology（2024）

Cited0Views0WOSBibtex

EPS4.01 Impact of 18 Months of Treatment with Elexacaftor/tezacaftor/ivacaftor on Clinical Outcomes in Children Aged 6–11 with CF – the RECOVER Study

P. McNally,K. Lester,B. Elnazir,D. Cox,M. Williamson,B. Linnane,L. Kirwan,P. O’Regan,C. Saunders,E. McKone,J.C. Davies

Journal of Cystic Fibrosis (2024): S43-S43

Cited0Views0Bibtex

P057 Measuring Adherence to Chronic Therapies over the First Year of Treatment with Elexacaftor/tezacaftor/ivacaftor (ETI) in People with Cystic Fibrosis (CF) Aged 6–11 Years – the RECOVER Study

S. Sutton,J. Hayden,M. Howlett,J. Davies,K. Lester,B. Elnazir,M. Williamson,E. McKone,D. Cox,B. Linnane,P. O’Regan,L. Kirwan,A. Quittner,P. McNally

Journal of Cystic Fibrosis (2024): S84-S84

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn